// App-Quantinova.ai

3432 : Infectious Outcomes of Pediatric Acute Lymphoblastic Leukemia Patients Presenting with Non-Neutropenic Fever

Researchers

Presenter

  • Pratik A. Patel

Principal Investigators

  • Nicholas P. DeGroote

  • Adam J. Esbenshade

  • William T. Cash

  • Sharon M. Castellino

  • Preeti Jaggi

  • Tamara P. Miller

Medical Centers

  • Aflac Cancer and Blood Disorders Center, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA, USA

  • Emory University, Aflac Cancer and Blood Disorders Center, Childrens Healthcare of Atlanta, Atlanta, GA

  • Vanderbilt-Ingram Cancer Center, Nashville, TNVanderbilt University, Nashville, TN

  • Aflac Cancer and Blood Disorders Center, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA, USA

  • Department of Pediatric Infectious Disease, Emory University School of Medicine/Children’s Healthcare of Atlanta, Atlanta, GA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • Cytarabine liposomal

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A